Skip to main content

Table 1 Clinicopathologic correlation for p-Skp2 expression in GC patients

From: Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer

Factors All patients No. of patients p
  N = 169 p-Skp2 negative p-Skp2 positive  
Age (y)     0.14
<60 84 45 39  
≥60 85 36 49  
Sex     0.39
Male 121 55 66  
Female 48 26 22  
Site     0.04
Upper 72 27 45  
Middle 25 12 13  
lower 72 42 30  
Tumor size     0.68
≤4 cm 62 31 31  
>4 cm 107 50 57  
Pathologic T classification     0.16
T1 17 12 5  
T2 32 12 20  
T3 41 18 23  
T4 79 39 40  
Pathologic N status     0.03
N negative 41 26 15  
N positive 128 55 73  
Pathologic stage (pTNM)     0.02
I 23 17 6  
II 45 21 24  
III 101 43 58  
p-mTOR expression     <0.0005
negative 86 66 20  
positive 83 15 68